Ellen Cavaleri

Ellen Cavaleri currently serves as the Head of Investor Relations at PTC Therapeutics, Inc. since November 2024. Prior to this role, Ellen held the position of Senior Vice President, Investor Relations and Communications at Lyra Therapeutics from September 2022 to June 2024, where Ellen was a member of the senior management team reporting to the CEO. Ellen's extensive experience in investor relations spans nearly a decade at Kadmon, where roles included Senior Vice President, Vice President, Director, and Manager of Investor Relations. Earlier in Ellen's career, Ellen worked as a Senior Associate at The Corkery Group from July 2008 to October 2014. Academically, Ellen holds an MBA from NYU Stern School of Business (2019-2021) and a BA in English from Vanderbilt University (2004-2008).